Viewing Study NCT03824951


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2026-01-03 @ 6:21 AM
Study NCT ID: NCT03824951
Status: UNKNOWN
Last Update Posted: 2019-01-31
First Post: 2019-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Anti-CD19 iCAR NK Cells in Relapsed and Refractory B Cell Lymphoma
Sponsor: Allife Medical Science and Technology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module